Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset
Background Early treatment discontinuation (ETD) is common in cancer treatment but understudied. We sought to identify clinical and treatment-related factors associated with ETD in a real-world cohort of patients with non-small-cell lung cancer (NSCLC). Patients and methods We analyzed lines of therapy (LoTs) including...